These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 378469)

  • 1. The pituitary-gonadal response to the gonadotrophin releasing hormone analogue D-Ser (TBU)6-Des Gly10-LHRH-ethylamide in normal men.
    Heath M; Scanlon MF; Mora B; Snow MH; Gomez-Pan A; Watson MJ; Mulligan F; Hall R
    Clin Endocrinol (Oxf); 1979 Mar; 10(3):297-303. PubMed ID: 378469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new LH-RH analogue (D-Ser(TBU)6-EA10-LH-RH) on gonadotrophin and gonadal steroid secretion in men.
    Wiegelmann W; Solbach HG; Kley HK; Nieschlag E; Rudorff KH; Krüskemper HL
    Horm Res; 1976; 7(1):1-10. PubMed ID: 793974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gonadotropin and testosterone secretion in normal human males after stimulation with gonadotropin-releasing hormone (GnRH) or potent GnRH analogs using different modes of application.
    Happ J; Hartmann U; Weber T; Cordes U; Beyer J
    Fertil Steril; 1978 Dec; 30(6):666-73. PubMed ID: 365598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contraception with an LHRH agonist: effect on gonadotrophin and steroid secretion patterns.
    Kuhl H; Jung C; Taubert HD
    Clin Endocrinol (Oxf); 1984 Aug; 21(2):179-88. PubMed ID: 6432376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects on gonadotrophin secretion and gonadal function in men during chronic treatment with a potent stimulatory luteinizing hormone-releasing hormone analogue.
    Bergquist C; Nillius SJ; Bergh T; Skarin G; Wide L
    Acta Endocrinol (Copenh); 1979 Aug; 91(4):601-8. PubMed ID: 386680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield GB; Island DP; Hoffman PG; LePage ME; Chan RL; Nerenberg CA; Kovacs WJ
    J Clin Endocrinol Metab; 1987 May; 64(5):931-6. PubMed ID: 3104388
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insensitivity of bonnet monkeys to (D-Ala6, Des-Gly10) LHRH ethylamide, a potent new luteinizing hormone releasing hormone analogue in rats and mice.
    Levitan D; Beitins IZ; Milton G; Barnes A; McArthur JW
    Endocrinology; 1977 Apr; 100(4):918-22. PubMed ID: 402262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mode of suppression of pituitary and gonadal function after acute or prolonged administration of a luteinizing hormone-releasing hormone antagonist in normal men.
    Pavlou SN; Wakefield G; Schlechter NL; Lindner J; Souza KH; Kamilaris TC; Konidaris S; Rivier JE; Vale WW; Toglia M
    J Clin Endocrinol Metab; 1989 Feb; 68(2):446-54. PubMed ID: 2537334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biologic activity of a potent analogue of gonadotropin-releasing hormone in normal and hypogonadotropic men.
    Crowley WF; Beitins IZ; Vale W; Kliman B; Rivier J; Rivier C; McArthur JW
    N Engl J Med; 1980 May; 302(19):1052-7. PubMed ID: 6767977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of single and repeated applications of a long-acting synthetic analogue of LHRH [D-Ser (TBU)6 EA10 LHRH] in the assessment of pituitary gonadotrophin secretory capacity.
    Vaughann Williams CA; McNeilly AS; Baird DT
    Clin Endocrinol (Oxf); 1980 Jul; 13(1):51-6. PubMed ID: 6777089
    [No Abstract]   [Full Text] [Related]  

  • 11. Blockade of LH and FSH secretion by LH-releasing hormone, by the LH-releasing hormone analogue, buserelin, and by combined treatment with LH-releasing hormone and oestradiol benzoate.
    Schuiling GA; Pols-Valkhof N; van der Schaaf-Verdonk GC; Koiter TR
    J Endocrinol; 1984 Dec; 103(3):301-9. PubMed ID: 6438265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pituitary and testicular response to luteinizing hormone releasing hormone in normal and sulpiride-induced hyperprolactinaemic men.
    Nakano R; Yagi S; Nishi T
    Exp Clin Endocrinol; 1988 May; 91(2):191-6. PubMed ID: 3137082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary-testis function in rats treated neonatally with a gonadotrophin-releasing hormone agonist: short- and long-term effects.
    Garnelo P; Pinilla L; Gaytan F; Aguilar E
    J Endocrinol; 1992 Aug; 134(2):269-77. PubMed ID: 1402537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic treatment with the gonadotropin-releasing hormone agonist D-Ser(TBU)6-EA10-LRH for contraception in women and men.
    Nillius SJ; Bergquist C; Wide L
    Int J Fertil; 1980; 25(3):239-46. PubMed ID: 6108935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative activity, plasma elimination and tissue degradation of synthetic luteinizing hormone releasing hormone and certain of its analogues.
    Swift AD; Crighton DB
    J Endocrinol; 1979 Jan; 80(1):141-52. PubMed ID: 372478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased potency of four analogues of LH-releasing hormone in man.
    Kastin AJ; Arimura A; Gonzalez-Barcena D; Coy DH; Miller MC; Nishi N; Lee L; Duron-Huerta H; Schalch DS; Schally AV
    Int J Fertil; 1974; 19(4):202-6. PubMed ID: 4376535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of oestrogen and GnRH agonist analogue-induced inhibition of the pituitary-testicular function in rat.
    Huhtaniemi IT; Warren DD; Catt KJ
    Acta Endocrinol (Copenh); 1983 Jun; 103(2):163-71. PubMed ID: 6305079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteinizing hormone (LH), follicle-stimulating hormone, and testosterone responses to consecutive injections of D-leucine-6-LH-releasing hormone ethylamide in normal men.
    Schwarzstein L; Aparicio NJ; Turner D; de Turner EA; Coy DH; Schally AV
    Fertil Steril; 1977 Apr; 28(4):451-5. PubMed ID: 321263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pituitary-testicular responses of estradiol-17 beta-implanted bull calves to continuous versus pulsatile infusion of luteinizing hormone releasing hormone.
    Schanbacher BD
    J Anim Sci; 1984 Apr; 58(4):943-8. PubMed ID: 6427169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermittent long-term administration of a potent gonadotropin-releasing hormone agonist in normal men.
    Doelle G; Linde R; Alexander N; Kirchner F; Vale W; Rivier J; Rabin D
    Int J Fertil; 1982; 27(4):234-7. PubMed ID: 6131043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.